SREBF1 and breast carcinoma: Our next experimental results demonstrated that metformin inhibited cholesterol level in breast cancer MDA-MB-231 cells with concomitant decrease of cholesterol regulatory gene expressions (e.g., HMGCoR, LDLR and SREBP1) (Fig 2).